{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Management of Tyrosine Kinase Inhibitor Anticancer Agents with Gastric Acid Suppression Medications

Activity Steps

1 Activity
2 Take Test 3Certificate

Description

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Purpose of Activity

To provide information on the drug-drug interactions between gastric acid suppression agents and tyrosine kinase inhibitor anticancer treatments.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Summarize the indications for gastric acid suppressing (GAS) medications and the prevalence of their use among people with cancer.
  2. Analyze the implications of research findings on the effects of GAS agents on patients who also received tyrosine kinase inhibitor (TKI) anticancer treatments.

Disclosures

The author(s), faculty, staff, and planners, including spouses/partners (if any), in any position to control the content of this activity have disclosed that they have no financial relationships with, or financial interests in, any commercial companies relevant to this educational activity.

Price: $10.00

Credits:

  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planner
Professions: Physician
Test Code: OT1019
Published: October 2019
Expires: 1/1/2026
Sources: Oncology Times
Required Passing Score: 7/10 (70%)
Authors: Lisa Lohr, PhARMD, BCOP, BCPS
Categories: Cancer , Gastrointestinal
Specialties: Hematology, Oncology
Topics: Cancer